Julia Fehniger

University of Chicago

Papers

1

Total Citations

29

H-Index

1

About

Julia Fehniger is a leading gynecologic oncologist whose research focuses on optimizing perioperative care and reducing complications in women undergoing surgery for gynecologic cancers. Her work has been instrumental in understanding and preventing venous thromboembolism (VTE), a major cause of morbidity in cancer patients. In her highly cited 2017 study, "Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer," Fehniger demonstrated that extended pharmacologic prophylaxis can significantly lower VTE risk in this population, challenging prior practice and informing updated clinical guidelines. With nearly 30 citations, this work underscores her impact on evidence-based surgical safety. Beyond this, Fehniger has contributed to research on surgical outcomes, health disparities, and quality of life in endometrial and ovarian cancer patients. Her achievements include leadership roles in national clinical trials and recognition for advancing minimally invasive surgical techniques. For students and researchers, Fehniger’s career exemplifies how targeted clinical research can directly improve patient outcomes and reshape standard care in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer
29 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Chicago

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago